코오롱티슈진

950160KOSDAQ기초 의약물질 제조업

52.7 / 100

Reference Date: 2026-04-13

Financial Score18.0 / 40

News Sentiment14.7 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is low with sound financial health but ROE is below the industry average. Slightly down 3.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Koongtishujin is a biotech company developing cell gene therapy drugs using its TG-C platform, currently conducting Phase III clinical trials for knee osteoarthritis and Phase II trials for hip osteoarthritis. As of July 2024, the Phase III trial for knee osteoarthritis has enrolled 1,066 patients. The company also operates a complex distribution business, selling health supplements, cosmetics, and wines through its W-store and L&B segments.

Number of Employees

58people

Average Salary

163.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 33.454.0Point

PBR

—Industry Average 2.033.5Point

ROE

-188.19Industry Average -4.293.5Point

43.9x industry avg (excellent)

Debt Ratio

6.60Industry Average 6.614.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.3% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼0.0% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -77.0% (declining, 3yr)

Detailed News Sentiment

8 totalPositive 2Neutral 6Negative 0Average Sentiment Score 58.8

Neutral
전쟁 '멈춤' 외국인 '질주'…코스피 7% 급등, 21만 전자 103만...
미국-이란 휴전 소식으로 국제유가와 환율이 안정되고 외국인 순매수가 유입되며 코스피가 7% 급등했다는 시장 전반에 대한 뉴스입니다.
Neutral
2주 휴전 소식에 안도한 증시…코스피 6% 급등 [시황]
2주 휴전 소식에 증시가 안도하며 코스피와 코스닥이 각각 6%, 5% 이상 급등했다는 시장 전반에 대한 뉴스입니다.
Neutral
코스피, 삼성전자 '어닝 서프라이즈'에 버텼다…5494.78 마감
삼성전자 어닝 서프라이즈에 힘입어 코스피가 상승 마감했으나 코스닥은 약세를 보였다는 시장 전반에 대한 뉴스가 보도되었습니다.

Detailed Momentum

52-week position6.0Point

52w upper range (70%)

Current 99,300Won52-week high 127,00052-week low 32,500

1-month return2.0Point

1m -3.78% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-30
Neutral주식등의대량보유상황보고서(일반)2026-03-27
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
Neutral정기주주총회결과2026-03-26
Neutral코스닥시장상장외국법인외부감사인선임ㆍ해임신고서2026-03-25